Your Genomics Strategy: Embrace Partnerships or Go-it-Alone

A new standard of care is emerging, characterized by broad-scale genetic screening and the integration of genomics into routine health care. As health systems increasingly recognize the impact genomics can make to improve patient care, they are exploring approaches to incorporate genomics into their strategic framework.

Learn from early genomics adopters, Mayo Clinic and Sanford Health, and their contrasting approaches to large-scale genomics programs: partnering with a genetic testing company vs. building in-house.

An engaging panel with leaders, Andy Danielsen, Chair of Mayo Clinic Ventures, Michael LeBeau, MD, SVP and Chief of Health Services Operations at Sanford Health, and James Lu, MD, PhD, CEO & Co-Founder at Helix, explaining the best approach to developing a genomics strategy that aligns with your health system’s strategy and goals.